These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1452442)
1. In vivo treatment with a monoclonal antibody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/lpr-lpr mouse. Nicoletti F; Meroni P; Di Marco R; Barcellini W; Borghi MO; Gariglio M; Mattina A; Grasso S; Landolfo S Immunopharmacology; 1992; 24(1):11-6. PubMed ID: 1452442 [TBL] [Abstract][Full Text] [Related]
2. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice. Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074 [TBL] [Abstract][Full Text] [Related]
3. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice. Nicoletti F; Di Marco R; Zaccone P; Xiang M; Magro G; Grasso S; Morrone S; Santoni A; Shoenfeld Y; Garotta G; Meroni P Eur J Immunol; 2000 Feb; 30(2):438-47. PubMed ID: 10671199 [TBL] [Abstract][Full Text] [Related]
4. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261 [TBL] [Abstract][Full Text] [Related]
5. Type I IFN protects against murine lupus. Hron JD; Peng SL J Immunol; 2004 Aug; 173(3):2134-42. PubMed ID: 15265950 [TBL] [Abstract][Full Text] [Related]
6. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044 [TBL] [Abstract][Full Text] [Related]
7. Function of the Th17/interleukin-17A immune response in murine lupus nephritis. Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550 [TBL] [Abstract][Full Text] [Related]
9. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice. Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294 [TBL] [Abstract][Full Text] [Related]
10. The characteristics of hematopoietic stem cells from autoimmune-prone mice and the role of neural cell adhesion molecules in abnormal proliferation of these cells in MRL/lpr mice. Wang X; Hisha H; Cui W; Song C; Mizokami T; Okazaki S; Li Q; Feng W; Kato J; Jiang S; Fan H; Ikehara S Haematologica; 2007 Mar; 92(3):300-7. PubMed ID: 17339178 [TBL] [Abstract][Full Text] [Related]
12. The effects of thymopentin on the development of SLE-like syndrome in the MRL/lpr-lpr mouse. Nicoletti F; Zaccone P; Magro G; Barcellini W; Cavallaro V; Belli G; Cocuzza C; di Marco R; Meroni PL Scand J Immunol; 1994 Nov; 40(5):549-56. PubMed ID: 7973460 [TBL] [Abstract][Full Text] [Related]
14. T cell-derived IFN-γ downregulates protective group 2 innate lymphoid cells in murine lupus erythematosus. Düster M; Becker M; Gnirck AC; Wunderlich M; Panzer U; Turner JE Eur J Immunol; 2018 Aug; 48(8):1364-1375. PubMed ID: 29671873 [TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of non-depleting anti-CD4 in MRL/Mp-lpr/lpr mice with active systemic lupus erythematosus and microscopic angiitis. Harper JM; Cook A Autoimmunity; 2001; 33(4):245-51. PubMed ID: 11683399 [TBL] [Abstract][Full Text] [Related]
16. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice. Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779 [TBL] [Abstract][Full Text] [Related]
17. Double-Edged Effect of Hydroxychloroquine on Human Umbilical Cord-Derived Mesenchymal Stem Cells Treating Lupus Nephritis in MRL/lpr Mice. Mai S; Zou L; Tian X; Liao X; Luan Y; Han X; Wei Y; Wu Y; Kuang S; Yang Y; Ma J; Chen Q; Yang J Mol Pharm; 2018 May; 15(5):1800-1813. PubMed ID: 29668284 [TBL] [Abstract][Full Text] [Related]
18. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. Takahashi S; Fossati L; Iwamoto M; Merino R; Motta R; Kobayakawa T; Izui S J Clin Invest; 1996 Apr; 97(7):1597-604. PubMed ID: 8601623 [TBL] [Abstract][Full Text] [Related]
19. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. Haas C; Ryffel B; Le Hir M J Immunol; 1997 Jun; 158(11):5484-91. PubMed ID: 9164971 [TBL] [Abstract][Full Text] [Related]
20. [Effect of CD40 siRNA on inflammatory response of MRL/Lpr mice]. Wang ZH; Zhang W; Zhang YQ; Pang CY; Wang YF Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):771-776. PubMed ID: 27752154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]